Mechanisms and Screening for Atherosclerosis in Adults With Vasculitis

Michael J Hendrickson1, Zachary S Wallace1,2

  • 1Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston (M.J.H., Z.S.W.).

Insights

Vascular inflammation in systemic vasculitis contributes to cardiovascular events via direct cardiac issues and accelerated atherosclerosis. More research is needed on screening and management for these patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Immunology

Background:

  • Vascular inflammation is central to systemic vasculitis and atherosclerosis.
  • Cardiovascular events are frequent in vasculitis patients due to direct vascular inflammation and accelerated atherosclerosis.
  • Cardiac involvement is noted across vasculitides, particularly Takayasu arteritis, polyarteritis nodosa, and eosinophilic granulomatosis with polyangiitis.

Purpose of the Study:

  • To review current evidence on epidemiology, mechanisms, and screening for atherosclerosis in primary systemic vasculitis.
  • To highlight the need for evidence-based guidelines for cardiovascular risk management in vasculitis.

Main Methods:

  • Literature review of recent studies on vasculitis and atherosclerosis.
  • Analysis of epidemiological data, pathogenic mechanisms, and screening strategies.
  • Synthesis of current knowledge regarding cardiovascular risk in primary systemic vasculitis.

Main Results:

  • Accelerated atherosclerosis is documented in Takayasu arteritis and antineutrophil cytoplasmic antibody-associated vasculitis.
  • Data on atherosclerosis in other vasculitis forms remains limited.
  • Existing screening and management strategies lack robust evidence-based guidelines.

Conclusions:

  • Cardiovascular risk in vasculitis patients requires comprehensive understanding and management.
  • Further research is essential to develop evidence-based guidelines for screening and managing atherosclerosis in primary systemic vasculitis.
  • Addressing both direct cardiac involvement and accelerated atherosclerosis is crucial for improving patient outcomes.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278